THOR-AABB Collaborative Session: Hemostatic Resuscitation Practice for Women, Prehospital Programs, and International Implementation

Speaker(s)

• AZ

  Alyssa Ziman, MD

  Section Chief, Transfusion Medicine; CLIA Medical Director, Clinical Laboratories, Ronald Reagan UCLA Medical Center
  Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA
  Los Angeles, California, United States

  Disclosure(s): No financial relationships to disclose
• 

  Phil Spinella, MD

  Co-Director, Trauma and Transfusion Medicine Center
  University of Pittsburgh
  SEWICKLEY, Pennsylvania, United States

  Disclosure(s): Cerus Corporation: Consultant/Advisory Board (Ongoing); Haima Therapeutics: Consultant/Advisory Board (Ongoing); Kalocyte: Full-time/Part-time Employee or Owner (Ongoing), Stock Shareholder (self-managed) (Ongoing); Octapharma: Consultant/Advisory Board (Ongoing)

  PDF
• 

  Molly Sherwood

  Director of Research
  Allo Hope Foundation

  Disclosure(s): No financial relationships to disclose

  PDF
• 

  Bryan Cotton, MD, MPH, FACS

  Professor of Surgery, McGovern Medical School Director of Trauma Surgery & Surgical Critical Care Fellowships
  Surgical Critical Care Fellowship Program
  Memorial Hermann Hospital
  Katy, Texas, United States

  Disclosure(s): Cerus, Global Blood Therapeutics, Forma: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Grifols: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Haemonetics: Consultant/Advisory Board (Ongoing); Teleflex: Consultant/Advisory Board (Ongoing)

  PDF

Program Chair(s)

• MY

  Mark Yazer, MD

  Professor of Pathology
  University of Pittsburgh
  Sewickley, Pennsylvania, United States

  Disclosure(s): Grifols: Consultant/Advisory Board (Ongoing), Honoraria (Ongoing); Hemanext: Consultant/Advisory Board (Ongoing); Terumo: Speaker's Bureau (Ongoing); Verax: Consultant/Advisory Board (Ongoing)

  PDF

Speaker(s)

• 

  John Holcomb, MD

  Professor of Surgery
  University of Alabama at Birmingham
  Birmingham, Alabama, United States

  Disclosure(s): Aspen Medical: Consultant/Advisory Board (Ongoing); CCJ Medical: Stock Shareholder (self-managed) (Ongoing); decisio health: Board of Directors (Ongoing), Stock Shareholder (self-managed) (Ongoing); Geneva Foundation: Consultant/Advisory Board (Ongoing); Hemostatics: Stock Shareholder (self-managed) (Ongoing); QinFlow: Stock Shareholder (self-managed) (Ongoing); UT Health Houston: Royalty (Ongoing); WFIRM: Consultant/Advisory Board (Ongoing); Zibrio: Board of Directors (Ongoing), Stock Shareholder (self-managed) (Ongoing)

  PDF
• 

  Audra Taylor

  Vice President for Blood Operations
  South Texas Blood &Tissue
  San Antonio, Texas, United States

  Disclosure(s): No financial relationships to disclose

  PDF
• 

  Joanne Pink, MD, FRCPA, FRACP

  Chief Medical Officer
  Australian Red Cross Lifeblood
  Everton Park, Victoria, Australia

  Disclosure(s): No financial relationships to disclose

  PDF
• 

  Vanessa Agostini

  Director of transfusion medicine department; director of regional blood center-Liguria Italy
  IRCCS Ospedale Policlinico San Martino Genova
  Rimini, Emilia-Romagna, Italy

  Disclosure(s): BioVIIIX: Consultant/Advisory Board (Terminated, October 28, 2023); CSL Behring: Consultant/Advisory Board (Terminated, April 18, 2024); Werfen/Instrumentation Laboratory: Honoraria (Terminated, May 18, 2023)

  PDF
• 

  Daise Muller, MD

  Medical chief
  SAMU Aeromédico de Santa Catarina, Brasil, Brazil

  Disclosure(s): No financial relationships to disclose

In this joint session organized by the Trauma, Hemostasis and Oxygenation Research (THOR) Network and the Association for the Advancement of Blood and Biotherapies (AABB) Collaborative, the latest evidence and expert opinion on emergency transfusion for females of childbearing potential with life-threatening bleeding, prehospital transfusion and emergency preparedness, and international perspectives on hemostatic resuscitation practice will be presented, including an update on the newly developed AABB Standards for Out of Hospital and Prehospital Administration Transfusion Services.

Agenda:

08:30-09:25 LTOWB and Equity of Care – Moderated by Alyssa Ziman
• Update on LTOWB and Evidence-Based Guideline Development to Reduce the Risk of HDFN – Phil Spinella
• Transfusion Related Alloimmunization/HDFN – Molly Sherwood
• Panel Discussion

09:25-09:45 The Transfusion Trials You Know and the Methods You Don’t Know – Moderated by Mark Yazer
• Speaker Bryan Cotton

09:45-10:00 Break

10:00-11:15 Designing a Prehospital Transfusion Program and Walking Blood Banks for Emergency Preparedness – Moderated by Eric Bank
• Three Different Prehospital Blood System Models – John Holcomb
• Is There a Place for Leukoreduction in Trauma Resuscitation? – Mark Yazer
• AABB Standards Committee Update on Prehospital Blood Standards and Walking Blood Banks for Emergency Preparedness - Audra Taylor
• Discussion

11:15-11:30 Break

11:30-12:30 International Hemostatic Resuscitation Practices
• Opening Remarks – Simon Stanworth and Alyssa Ziman
• Discussion – Panelists: Jo Pink, Australia; Eilat Shinar, Israel; Vanessa Agostini, Italy; Daíse Müller, Brazil